The Brain Reset Breakthrough - The Neuronova Story | Ep 32 | Fountain of Vitality

Researchers spent seven years failing to find a non-drug way to produce dopamine in the brain. Then one scientist, on a hunch, tried 80 Hz vibration on lab rats and found 200% of baseline dopamine in a single session. That accident became a NIH-funded clinical trial, a 60% reduction in generalized anxiety, and eventually a chair you can sit in at home. Thomas Wilkinson lost his brother to a methadone overdose. Now he's the CEO bringing that technology to families across America. In this episode of Fountain of Vitality, host LaMont Leavitt sits down with Thomas Wilkinson, CEO of NeuroNova, to explore how targeted spinal vibration at 80 Hz triggers a physiological release of dopamine without drugs or invasive procedures. Thomas shares the research origins at Brigham Young University, his personal battle with anxiety and chemical dependency on four prescribed medications, and what a world-renowned sleep researcher discovered when he checked Thomas's Oura Ring data at a conference in Arizona. If anxiety, insomnia, or stress has you searching for something beyond medication, this conversation will change how you think about what's possible. Listen now on Fountain of Vitality and share it with someone who needs to hear it. Follow the Fountain of Vitality podcast: Website - FountainofVitality.com | Tiktok - @FountainofVitalitypod | YouTube - @FountainofVitalityshow | Tumblr - @FountainofVitality | Facebook - FountainofVitalityShow | Rumble - Fountain_of_Vitality | Instagram - @FountainofVitalitypodcast | Email - [email protected] Follow LaMont Leavitt: LinkedIn - @LaMontJLeavitt/ | Twitter/X - @ljleavitt1 |InnoviHealth Website - innoviHealth.com Follow Thomas Wilkinson, CEO of NeuroNova: LinkedIn - @Thomas-Wilkinson-7b74316a | Website - NeuroNovaCo.com | Instagram - @NeuroNovaCo | TikTok/X- @NeuroNovaCo | LinkedIn - @NeuroNovaCo GUEST INFO: Thomas Wilkinson, CEO of NeuroNova Thomas Wilkinson is the CEO of NeuroNova, a company commercializing 80 Hz vibration technology originally developed at Brigham Young University to help the brain produce dopamine naturally. After losing his brother in a substance use recovery center and battling his own chemical dependency on anxiety medications, Thomas purchased the technology and partnered with the lead neuroscientist to bring it to market. NeuroNova is currently in a multi-state FDA trial funded by a $3.5 million NIH grant.